Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1980 4
1981 2
1983 2
1985 2
1986 8
1987 4
1988 2
1990 2
1991 2
1992 1
1993 2
1994 1
1995 2
1996 2
1997 1
1998 2
1999 3
2000 5
2001 5
2002 3
2003 5
2004 5
2005 4
2006 2
2007 6
2008 4
2009 1
2010 5
2011 6
2012 6
2013 7
2014 10
2015 13
2016 13
2017 7
2018 4
2019 3
2020 5
2021 2
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

145 results

Results by year

Filters applied: . Clear all
Page 1
[Proteasome inhibitors in cancer therapy].
Romaniuk W, Ołdziej AE, Zińczuk J, Kłoczko J. Romaniuk W, et al. Among authors: kloczko j. Postepy Hig Med Dosw (Online). 2015 Dec 31;69:1443-50. Postepy Hig Med Dosw (Online). 2015. PMID: 27259216 Free article. Review. Polish.
Protein Z concentration in multiple myeloma patients.
Bolkun L, Piszcz J, Oleksiuk J, Luksza E, Galar M, Szumowska A, Kloczko J. Bolkun L, et al. Among authors: kloczko j. Thromb Res. 2011 Nov;128(5):401-2. doi: 10.1016/j.thromres.2011.07.040. Epub 2011 Aug 24. Thromb Res. 2011. PMID: 21868070 No abstract available.
The Outcomes of Ponatinib Therapy in Patients With Chronic Myeloid Leukemia Resistant or Intolerant to Previous Tyrosine Kinase Inhibitors, Treated in Poland Within the Donation Program.
Sacha T, Szczepanek E, Dumnicka P, Góra-Tybor J, Niesiobędzka-Krężel J, Prejzner W, Wasilewska E, Kłoczko J, Ciepłuch H, Makowska W, Patkowska E, Wasilewska J, Bober G, Kopera M, Wichary R, Kroll-Balcerzak R, Gromek T, Wach M, Rudkowska-Kazanowska A, Świniarska M, Paczkowska E, Biernat M, Joks M, Oller M, Kasza R, Kostyra A, Gil J, Grzybowska-Izydorczyk O. Sacha T, et al. Among authors: kloczko j. Clin Lymphoma Myeloma Leuk. 2022 Jun;22(6):405-415. doi: 10.1016/j.clml.2021.11.012. Epub 2021 Nov 20. Clin Lymphoma Myeloma Leuk. 2022. PMID: 34933827 Free article.
Continuous lenalidomide treatment for newly diagnosed multiple myeloma.
Palumbo A, Hajek R, Delforge M, Kropff M, Petrucci MT, Catalano J, Gisslinger H, Wiktor-Jędrzejczak W, Zodelava M, Weisel K, Cascavilla N, Iosava G, Cavo M, Kloczko J, Bladé J, Beksac M, Spicka I, Plesner T, Radke J, Langer C, Ben Yehuda D, Corso A, Herbein L, Yu Z, Mei J, Jacques C, Dimopoulos MA; MM-015 Investigators. Palumbo A, et al. Among authors: kloczko j. N Engl J Med. 2012 May 10;366(19):1759-69. doi: 10.1056/NEJMoa1112704. N Engl J Med. 2012. PMID: 22571200 Free article. Clinical Trial.
Efficacy and safety of fludarabine and cyclophosphamide combined therapy in patients with refractory/recurrent B-cell chronic lymphocytic leukaemia (B-CLL)-Polish multicentre study.
Kowal M, Dmoszyńska A, Lewandowski K, Hellmann A, Wegrzyn J, Skotnicki AB, Wołowiec D, Kuliczkowski K, Piszcz J, Kłoczko J, Roznowski K, Komarnicki M. Kowal M, et al. Among authors: kloczko j. Leuk Lymphoma. 2004 Jun;45(6):1159-65. doi: 10.1080/10428190310001624152. Leuk Lymphoma. 2004. PMID: 15359995 Review.
A five-year follow-up of untreated patients with chronic lymphocytic leukaemia treated with ofatumumab and chlorambucil: final analysis of the Complement 1 phase 3 trial.
Offner F, Robak T, Janssens A, Govind Babu K, Kloczko J, Grosicki S, Mayer J, Panagiotidis P, Schuh A, Pettitt A, Montillo M, Werner O, Vincent G, Khanna S, Hillmen P. Offner F, et al. Among authors: kloczko j. Br J Haematol. 2020 Sep;190(5):736-740. doi: 10.1111/bjh.16625. Epub 2020 Mar 31. Br J Haematol. 2020. PMID: 32236950 Free article. Clinical Trial.
The Real-World Evidence on the Fragility and Its Impact on the Choice of Treatment Regimen in Newly Diagnosed Patients with Multiple Myeloma over 75 Years of Age.
Tyczyńska A, Krzempek MK, Cortez AJ, Jurczyszyn A, Godlewska K, Ciepłuch H, Subocz E, Hałka J, Kulikowska de Nałęcz A, Wiśniewska A, Świderska A, Waszczuk-Gajda A, Drozd-Sokołowska J, Guzicka-Kazimierczak R, Wiśniewski K, Porowska A, Knopińska-Posłuszny W, Kłoczko J, Rzepecki P, Woszczyk D, Symonowicz H, Basak GW, Zdziarska B, Jamroziak K, Zaucha JM. Tyczyńska A, et al. Among authors: kloczko j. Cancers (Basel). 2023 Jul 2;15(13):3469. doi: 10.3390/cancers15133469. Cancers (Basel). 2023. PMID: 37444579 Free PMC article.
145 results